Insulin pumps and blood glucose meters are too imprecise
Many blood glucose meters are too inaccurate, according to a communication from the European Association for the Study of Diabetes (EASD). There are deviations of ten to twenty percent between the different devices, the experts reported on Tuesday in advance of the 48th annual conference of the EASD in Berlin at the beginning of October.
Professor Dr. med. Andreas Pfeiffer, diabetologist at the Charité in Berlin and head of the clinical nutrition department at the German Institute for Nutritional Research explained that the values of the various blood glucose meters vary widely. In order to dose the required insulin correctly, the blood sugar level must be determined as precisely as possible. With deviations of up to twenty percent, high blood sugar could be almost a question of the diagnostic device and not of the illness itself.
Deviations of up to 20 percent in blood glucose meters According to the experts, the determination of exact blood sugar values and the precise dosage of the insulin pumps is essential for effective treatment of diabetes. The EASD President, Professor Andrew Boulton from Manchester, criticized at the press conference on Tuesday in Berlin, "that the current regulations within the European Union for the quality control of blood glucose meters, insulin pumps and sensors in the field of diabetology are completely inadequate. “This would make the self-measurement of blood sugar levels, which are the basis of every successful insulin treatment, significantly more difficult. Diabetes patients should be able to rely on the accuracy of these meters, Boulton said. According to the expert, there are also considerable deficits in insulin pumps. The insulin pumps would give people with diabetes very good treatment, but approval and quality control are much worse in Europe than in the United States, for example. Such negligence would "no one accept in cars", added Viktor Jörgen from the European Society for Diabetes Research (EASD).
Improvement of quality controls required by the EU In view of the existing shortcomings, EADS called for much tougher criteria in quality assurance for devices for self-monitoring of blood sugar. Diabetes patients, "whose insulin pumps or sensors are paid for by health insurers, should also be included in the registry in order to identify technical problems with the devices in good time," the EADS press release on Tuesday. The European Society for Diabetes Research is extremely critical of current considerations at EU level and expressed concern that the EU's latest drafts will not bring progress.
World's largest diabetes congress in Berlin At the world's largest diabetes congress around 18,000 participants from 130 countries are expected in Berlin from October 1st to 5th to gather information about the latest results of diabetes research and to discuss them critically. For example, presentations on the possible connections between insulin treatments and cancer are on the program. The much-discussed alleged connection between viral diseases and type 1 diabetes is also discussed here again. Furthermore, the potential of the new generation of diabetes medications, which cause a lowering of the blood sugar level without the risk of hypoglycaemia, will be discussed. (fp)
Diabetes test strips regulation restricted
Diabetes: Health insurance companies delete test strips
Diabetes: twelve risk factors decoded
Diabetes is not a fate
Type II Diabetes Cure Without Medications?
Image: Michael Horn / pixelio.de